TriangleFOR PATIENTS · SOURCE READING
Certain factors affect prognosis (chance of recovery) and treatment options.
Source: Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
The prognosis and treatment options for AML depend on:
Source links and citations
the person's age
whether the leukemia has spread to the CNS
whether the patient has a systemic infection at the time of diagnosis
whether the patient has a very high white blood cell count at the time of diagnosis
the subtype of AML
whether the patient received chemotherapy or radiation therapy in the past to treat a different cancer
whether there is a history of a blood disorder such as myelodysplastic syndrome
whether the cancer has been treated before or recurred (come back)
Source links and citations
It is important to treat AML right away. Older age at diagnosis may be linked to lower remission rates and more complications.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice